Softwr

Research · head to head

Form Bio vs Labguru

Form Bio logo

Form Bio

Research

Computational platform for cell and gene therapy design and manufacturability

From
On request
Rated
-
Labguru logo

Labguru

Research

Electronic lab notebook, LIMS and inventory in one system, now sold under the Cenevo group

From
On request
Rated
-

The short version

  • Each has a real cost: Form Bio the company has pivoted twice since spinning out of Colossal Biosciences in 2022, from general computational life sciences to cell and gene therapy and then to AAV manufacturability, so any evaluation more than a year old describes a product that is no longer the commercial focus.; Labguru ownership changed twice in short order, to Battery Ventures in 2024 and then into the Cenevo brand with Titian Software in 2025, so the medium-term roadmap is a group strategy decision rather than a product one and buyers should ask directly what happens to the notebook.
  • They diverge on capability: Form Bio covers FormManufacturing, Labguru covers Combined ELN and LIMS.
  • Prices and features above were last checked on 31 August 2026.

Where they differ

Only the attributes on which Form Bio and Labguru actually diverge.

Attributes where Form Bio and Labguru differ
AttributeForm BioLabguru
PlatformsWeb, CloudWeb, iOS, Android, On-premise

Identical on both: starting price (On request), pricing model (quote), free tier (No), user rating (Not yet rated), category (Research).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in Form Bio

  • FormManufacturing
  • Payload design optimisation
  • Genome integrity analysis
  • Manufacturability prediction
  • In silico workflows
  • Scale-up monitoring
  • Cell and gene therapy focus
  • Collaboration

Only in Labguru

  • Combined ELN and LIMS
  • Validated cloud hosting
  • Inventory and stock
  • Chemistry module
  • Equipment management
  • Electronic batch records
  • Label Wizard
  • API and developer tools

What people use each for

The jobs each tool is most often brought in to do.

Form Bio

  • A gene therapy developer discovering manufacturability problems with an AAV construct late in process development and wanting to move that analysis earliernot Labguru
  • A biotech comparing several candidate payload designs in silico before committing to expensive production runsnot Labguru
  • A CDMO characterising what a client construct actually produces against what was specifiednot Labguru
  • A programme team needing genome integrity evidence to support regulatory conversations about product consistencynot Labguru

Labguru

  • A biotech that wants experiment records and sample inventory in one system instead of paying for an ELN and a LIMS separatelynot Form Bio
  • A chemistry group needing structure registration attached to the experiment rather than in a standalone databasenot Form Bio
  • A contract research organisation that must show sample traceability from receipt to reported result during a client auditnot Form Bio
  • An academic institute standardising dozens of small labs off shared spreadsheets and paper notebooks onto one searchable recordnot Form Bio

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

Form Bio

  • The company has pivoted twice since spinning out of Colossal Biosciences in 2022, from general computational life sciences to cell and gene therapy and then to AAV manufacturability, so any evaluation more than a year old describes a product that is no longer the commercial focus.
  • The current offering launched AAV-focused, so developers working in lentiviral, mRNA or cell therapy modalities are outside the scope the platform was built and validated for.
  • No pricing is published and engagements are scoped per programme, which makes it impossible to size the commitment before entering a sales process.
  • This is a young venture-funded company whose analyses feed regulatory-facing decisions, so continuity of the vendor over a multi-year development programme is a genuine diligence question rather than a formality.
  • Predictive manufacturability models need real production data to be trustworthy, and the value depends on how much of that a young vendor has accumulated, which is difficult for a buyer to verify independently.

Labguru

  • Ownership changed twice in short order, to Battery Ventures in 2024 and then into the Cenevo brand with Titian Software in 2025, so the medium-term roadmap is a group strategy decision rather than a product one and buyers should ask directly what happens to the notebook.
  • The validated GxP hosting option is a separate commercial line, not a configuration setting, so a lab that discovers mid-project that it needs a validated instance faces a new contract and a new price rather than an upgrade.
  • Being both an ELN and a LIMS means it is shallower than dedicated tools in each role; high-throughput sample management and deep bioinformatics workflows both hit limits that a specialist would not.
  • No pricing is published at all, and modules such as chemistry, batch records and equipment are quoted on top, so the real annual figure only appears after a sales process.
  • Validation, SOPs and periodic revalidation after vendor releases are the customer obligation on a regulated instance, and cloud release cadence means that revalidation is a recurring internal cost that never appears on the vendor quote.

Pricing, plan by plan

Form Bio

On request
  • FormManufacturing$undefined/year
    • Pricing only through a sales process
    • Scoped per therapeutic programme rather than per seat
    • AAV-focused offering at launch

Labguru

On request
  • Labguru$undefined/year
    • Priced per user per year on quotation with volume tiers
    • ELN, LIMS and inventory in the base platform
    • Chemistry, batch records and equipment modules quoted separately

Which should you pick?

Choose Form Bio if

  • You need formmanufacturing.
  • You work on Web, Cloud.
  • You also want payload design optimisation.

Choose Labguru if

  • You need combined eln and lims.
  • You work on Web, iOS, Android, On-premise.
  • You also want validated cloud hosting.

Questions people ask

Is Form Bio or Labguru better?
Neither clearly leads. Form Bio starts at On request and Labguru at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, Form Bio or Labguru?
Form Bio starts at On request and Labguru at On request.
Does Form Bio or Labguru run on more platforms?
Form Bio runs on Web, Cloud. Labguru runs on Web, iOS, Android, On-premise.
What is Form Bio best used for?
Form Bio is most often used for a gene therapy developer discovering manufacturability problems with an aav construct late in process development and wanting to move that analysis earlier, a biotech comparing several candidate payload designs in silico before committing to expensive production runs, a cdmo characterising what a client construct actually produces against what was specified, a programme team needing genome integrity evidence to support regulatory conversations about product consistency. Of those, a gene therapy developer discovering manufacturability problems with an aav construct late in process development and wanting to move that analysis earlier and a biotech comparing several candidate payload designs in silico before committing to expensive production runs are not what Labguru is typically brought in for.
What can Form Bio do that Labguru cannot?
Form Bio covers FormManufacturing, Payload design optimisation, Genome integrity analysis, Manufacturability prediction. Labguru covers Combined ELN and LIMS, Validated cloud hosting, Inventory and stock, Chemistry module.

Answered from the vendors’ own pages

Form Bio: What does Form Bio sell now?

FormManufacturing, launched in 2026, an AAV-focused platform for predicting, optimising and monitoring manufacturability of genetic medicines from construct design through scale-up.

Labguru: Who owns Labguru now?

Battery Ventures acquired it in April 2024. Since July 2025 it operates under the Cenevo brand following a merger with Titian Software.

Form Bio: Is it still a general bioinformatics platform?

No. It has narrowed from broad computational life sciences tooling to cell and gene therapy, and within that to AAV.

Labguru: Is it an ELN or a LIMS?

Both, in one product. That is the main reason labs choose it, and also why it is shallower than a specialist in each role.

Form Bio: Where did the company come from?

It spun out of Colossal Biosciences in 2022.

Labguru: Does it support GxP work?

Yes, through a separately contracted validated cloud instance. Validation for your intended use remains your responsibility.

Form Bio: Is pricing published?

No. Engagements are scoped per programme through a sales process.

Labguru: Is pricing published?

No. It is quoted per user per year, with modules and validated hosting priced on top.

Share

Related pages

Other head to heads